BGA-002

N/A

Report date: 2026/04/14 20:00:15

NME

Base Information

Drug NameBGA-002

Drug Alias Nameanti-MYCN PNA16-base single-stranded peptide nucleic acid oligonucleotide linked to a 7 amino acid peptideAnti-MYCN Peptide-nucleic Acid (Biogenera)BGA-002

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Peptide nucleic acids

Mechanisms of ActionN-myc proto-oncogene protein inhibitors

TargetsN-myc proto-oncogene protein

Therapy Area/IndicationsSmall Cell Lung Carcinoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryItaly

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBiogenera SPA

China Registration ClassN/A

Develop Information

Active CompaniesBiogenera SPA

Inactive CompaniesN/A

Active IndicationsSmall Cell Lung Carcinoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A